Drugs in R&D publishes original research and reviews from all phases of drug development and on clinical use of drugs following approval.
The journal was re-launched in 2010 as the first Open Access journal from Adis, making all content from 2010 onwards freely available online. Pre-2010 content is not available as Open Access.
Manuscripts accepted for publication by the journal are subject to an article processing charge (APC). Details of the current APC and open access funding and support services are available here.
Drugs in R&D offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).
Contact: For more information about the journal, including pre-submission enquiries, please contact Stephen O'Connell at stephen.oconnell@springer.com